The combination of CEA and yGT was particularly advantageous for separating pelvic or local recurrence from hepatic metastases. In the former there was a moderate rise of CEA but little increase of yGT whereas in hepatic metastases the yGT was elevated. These tests, when considered with relevant clinical history, can readily distinguish hepatic metastases from non-malignant disease of the liver. Approximately 10% of outpatients who were symptom free and without apparent recurrence showed a moderate elevation (40-100 units) of yGT without corresponding increase in CEA, when examined 3 months to 13 years after excision of the primary. The significance of this biochemical abnormality is, as yet, unknown.
The combination of CEA and yGT was particularly advantageous for separating pelvic or local recurrence from hepatic metastases. In the former there was a moderate rise of CEA but little increase of yGT whereas in hepatic metastases the yGT was elevated. These tests, when considered with relevant clinical history, can readily distinguish hepatic metastases from non-malignant disease of the liver. Approximately 10% of outpatients who were symptom free and without apparent recurrence showed a moderate elevation (40-100 units) of yGT without corresponding increase in CEA, when examined 3 months to 13 years after excision of the primary. Bone scanning is recognized to be more effective than radiology in the demonstration of skeletal metastases. The established bone scanning agents, strontium-87m and fluorine-18, are not entirely satisfactory. Recently, technetium labelled phosphate compoundspolyphosphate, pyrophosphate and ethane hydroxy diphosphonate-have become available for skeletal scanning. We have now performed over 200 consecutive studies in man and no toxic effects have been noted. A study of the relative efficacy of these agents in patients with metastatic disease, and in normal subjects, is described. Adequate visualization of the skeleton has been obtained and comparison of the scans and x-rays suggests that these compounds are of definite value in the investigation of malignant disease of the skeleton. Cultured Yoshida lymphosarcoma cells resistant (R) to treatment with sulphur mustard suffered much less chromosome damage than sensitive (S) cells in spite of equal alkylation of DNA, RNA and protein in R and S cells. The R and S cell lines were equally sensitive to x-rays and sustained the same amount of chromosome damage. DNA repair synthesis was equal in R and S cells after sulphur mustard or x-ray treatment.
Much less chromosome damage was found in L5178Y mouse lymphoma cells resistant to x-irradiation than in radiationsensitive cells but the amount of DNA repair was similar.
Thus, drug and radiation resistance is accompanied by, and perhaps mediated through, a reduced amount of induced chromosome damage but is not quantitatively related to DNA repair capacity. The effects of IRCF 159 on macromolecular synthesis in cultured cells led to the suggestion of a possible radiomimetic action (Creighton and Birnie, Int. J. Cancer, 1970, 5, 47) . We have found a dose-dependent inhibition of the growth (cell numbers) of BHK-21S cells approaching 100% at >100 ,umol/l (27 ug/ml). Continuous exposure to a range of doses >5 ,tmol/l produced a hyperbolic decrease in survival (colony forming assay). Such a response is generally associated with antimetabolites but in this case the hyperbolic curve seems more likely to be caused by a protective effect which is seen with ICRF 159 at high doses (ca. 400 tzmol/l). Cells growing in monolayer culture pass from a period of exponential growth into a stationary (or plateau) phase. This phase is characterized by a reduction in the tritiated thymidine labelling index, an increase in the cell cycle time and a large proportion of cells which are " out of cycle " (Hahn and Little, Curr. Topics Radiat. Res., 1972, 8, 39) . There is therefore a similarity between stationary phase cultures and solid tumours which also contain "non-cycling " cells.
MECHANISM OF ACTION STUDIES
Dose-response curves are presented for the effect of a number of chemotherapeutic agents on EMT6 mouse tumour cells in exponential and stationary phases of growth. The similarities and differences between our results and those of other workers are discussed. 
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